⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10570548 | 0.71 | — | — | |
| SCHEMBL2480054 | 0.69 | — | — | |
| SCHEMBL8717262 | 0.69 | — | — | |
| SCHEMBL2540229 | 0.69 | — | — | |
| SCHEMBL243965 | 0.69 | — | — | |
| SCHEMBL13840590 | 0.67 | CHRM2 (0.45) | — | |
| SCHEMBL239749 | 0.67 | — | — | |
| SCHEMBL19052288 | 0.67 | — | — | |
| SCHEMBL10265931 | 0.65 | GAA (0.36) | — | |
| SCHEMBL10568969 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1628621-A2 | POLYMERIC CONJUGATES FOR TISSUE ACTIVATED DRUG DELIVERY | Vectramed, Inc. (US) | 2006-03-01 | — | — | EP | claimed |
| WO-2004110358-A2 | POLYMERIC CONJUGATES FOR TISSUE ACTIVATED DRUG DELIVERY | VECTRAMED, INC. (US) | 2004-12-23 | — | — | WO | claimed |
| US-20040228831-A1 | Polymeric conjugates for tissue activated drug delivery | VECTRAMED, INC. | 2004-11-18 | — | — | US | claimed |